High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy
Yu Fujiwara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K. Nesline, Jeffrey M. Conroy, Paul DePietro, Sarabjot Pabla, Scott M. Lippman, Razelle Kurzrock
Research output: Contribution to journal › Article › peer-review
3Scopus
citations
Fingerprint
Dive into the research topics of 'High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy'. Together they form a unique fingerprint.